PHIO Annual Cash & Cash Equivalents
$8.49 M
-$3.29 M-27.93%
01 December 2023
Summary:
As of January 23, 2025, PHIO annual cash & cash equivalents is $8.49 million, with the most recent change of -$3.29 million (-27.93%) on December 1, 2023. During the last 3 years, it has fallen by -$5.75 million (-40.40%). PHIO annual cash & cash equivalents is now -64.71% below its all-time high of $24.06 million, reached on December 31, 2021.PHIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHIO Quarterly Cash And Cash Equivalents
$5.39 M
+$692.00 K+14.73%
01 September 2024
Summary:
As of January 23, 2025, PHIO quarterly cash and cash equivalents is $5.39 million, with the most recent change of +$692.00 thousand (+14.73%) on September 1, 2024. Over the past year, it has dropped by -$3.02 million (-35.89%). PHIO quarterly cash and cash equivalents is now -83.51% below its all-time high of $32.70 million, reached on March 31, 2021.PHIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHIO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.9% | -35.9% |
| 3 y3 years | -40.4% | -35.9% |
| 5 y5 years | -42.9% | -35.9% |
PHIO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.7% | at low | -77.6% | +14.7% |
| 5 y | 5-year | -64.7% | +22.4% | -83.5% | +14.7% |
| alltime | all time | -64.7% | +1587.9% | -83.5% | +1409.8% |
Phio Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.39 M(+14.7%) |
| June 2024 | - | $4.70 M(-27.4%) |
| Mar 2024 | - | $6.47 M(-23.7%) |
| Dec 2023 | $8.49 M(-27.9%) | $8.49 M(+1.0%) |
| Sept 2023 | - | $8.41 M(-25.6%) |
| June 2023 | - | $11.31 M(+25.1%) |
| Mar 2023 | - | $9.04 M(-23.3%) |
| Dec 2022 | $11.78 M(-51.0%) | $11.78 M(-18.7%) |
| Sept 2022 | - | $14.48 M(-19.6%) |
| June 2022 | - | $18.02 M(-11.9%) |
| Mar 2022 | - | $20.46 M(-15.0%) |
| Dec 2021 | $24.06 M(+68.9%) | $24.06 M(-9.3%) |
| Sept 2021 | - | $26.53 M(-9.8%) |
| June 2021 | - | $29.43 M(-10.0%) |
| Mar 2021 | - | $32.70 M(+129.5%) |
| Dec 2020 | $14.24 M(+105.4%) | $14.24 M(-15.6%) |
| Sept 2020 | - | $16.87 M(-10.6%) |
| June 2020 | - | $18.86 M(+42.0%) |
| Mar 2020 | - | $13.28 M(+91.6%) |
| Dec 2019 | $6.93 M(-53.4%) | $6.93 M(-20.4%) |
| Sept 2019 | - | $8.71 M(-19.5%) |
| June 2019 | - | $10.82 M(-15.1%) |
| Mar 2019 | - | $12.75 M(-14.3%) |
| Dec 2018 | $14.88 M | $14.88 M(+359.2%) |
| Sept 2018 | - | $3.24 M(-39.0%) |
| June 2018 | - | $5.32 M(+104.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $2.61 M(-27.2%) |
| Dec 2017 | $3.58 M(-72.3%) | $3.58 M(-33.9%) |
| Sept 2017 | - | $5.42 M(-29.7%) |
| June 2017 | - | $7.70 M(-24.5%) |
| Mar 2017 | - | $10.21 M(-20.9%) |
| Dec 2016 | $12.91 M(+152.2%) | $12.91 M(+442.5%) |
| Sept 2016 | - | $2.38 M(-37.9%) |
| June 2016 | - | $3.83 M(-8.6%) |
| Mar 2016 | - | $4.19 M(-18.1%) |
| Dec 2015 | $5.12 M(-39.8%) | $5.12 M(+26.8%) |
| Sept 2015 | - | $4.04 M(-32.6%) |
| June 2015 | - | $5.99 M(-9.0%) |
| Mar 2015 | - | $6.58 M(-22.6%) |
| Dec 2014 | $8.50 M(-25.4%) | $8.50 M(+65.6%) |
| Sept 2014 | - | $5.13 M(-56.9%) |
| June 2014 | - | $11.91 M(+32.2%) |
| Mar 2014 | - | $9.01 M(-20.9%) |
| Dec 2013 | $11.39 M(+122.2%) | $11.39 M(+66.4%) |
| Sept 2013 | - | $6.85 M(-20.3%) |
| June 2013 | - | $8.59 M(-56.3%) |
| Mar 2013 | - | $19.64 M(+283.1%) |
| Dec 2012 | $5.13 M(+919.3%) | $5.13 M(-18.3%) |
| Sept 2012 | - | $6.28 M(-17.1%) |
| June 2012 | - | $7.58 M(+2021.8%) |
| Mar 2012 | - | $357.00 K(-29.0%) |
| Dec 2011 | $503.00 K | $503.00 K |
FAQ
- What is Phio Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Phio Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Phio Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of PHIO is $8.49 M
What is the all time high annual cash & cash equivalents for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual cash & cash equivalents is $24.06 M
What is Phio Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, PHIO annual cash & cash equivalents has changed by -$3.29 M (-27.93%)
What is Phio Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PHIO is $5.39 M
What is the all time high quarterly cash and cash equivalents for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly cash and cash equivalents is $32.70 M
What is Phio Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, PHIO quarterly cash and cash equivalents has changed by -$3.02 M (-35.89%)